Global Radiopharmaceuticals Market Key Players Competitive Survey Report 2023
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Radiopharmaceuticals market size in 2022 is 5200.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 9.40% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Radiopharmaceuticals market include Cardinal Health (U.S.), GE Healthcare (U.S.), Lantheus Medical Imaging (U.S.), Bayer AG (Germany), and Bracco Imaging (Italy). The share of the top 3 players in the Radiopharmaceuticals market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Radiopharmaceuticals market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Diagnostic Procedures accounted for XX% of Radiopharmaceuticals market in 2022. Therapeutic Procedures share of XX%.
Nuclear Reactors accounted for XX% of the Radiopharmaceuticals market in 2022. Cyclotrons accounts for XX%.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Radiopharmaceuticals market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.
The report analyzes the key trends in each segment of the global Radiopharmaceuticals market along with global and country-level forecasts from 2023 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.
Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Radiopharmaceuticals market for 2017-2028.
The research report provides the latest information on the market drivers, challenges and opportunities of the global Radiopharmaceuticals market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Radiopharmaceuticals industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Key Regions Covered in This Report Are
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Some of the major players operating in the global market include:
Cardinal Health (U.S.)
GE Healthcare (U.S.)
Lantheus Medical Imaging (U.S.)
Bayer AG (Germany)
Bracco Imaging (Italy)
Nordion (Canada)
Advanced Accelerator Applications (France)
NTP Radioisotopes (South Africa)
NorthStar Medical Radioisotopes (U.S.)
Eckert & Ziegler (Germany)
Braun Melsungen AG (Germany)
Smith+Nephew (Germany)
Segment by Type
Diagnostic Procedures
Therapeutic Procedures
Source
Segment by Application
Nuclear Reactors
Cyclotrons
Table of Content
1 Radiopharmaceuticals Market Introduction and Overview
1.1 Radiopharmaceuticals Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Radiopharmaceuticals Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Radiopharmaceuticals Revenue and Market Share by Type
2.3 Global Radiopharmaceuticals Sales and Market Share by Type
3 Global Radiopharmaceuticals Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Radiopharmaceuticals Revenue Market Share by Application (2018-2023)
3.3 Global Radiopharmaceuticals Sales Market Share by Application (2018-2023)
4 Global Market Growth Trends Analysis
4.1 Global Radiopharmaceuticals Market Size (2018-2023)
4.2 Radiopharmaceuticals Growth Trends Analysis by Regions
4.2.1 Radiopharmaceuticals Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Radiopharmaceuticals Historic Revenue Market Size by Regions (2018-2023)
4.2.3 Radiopharmaceuticals Historic Sales Market Size by Regions (2018-2023)
4.2.4 North America Radiopharmaceuticals Market Size (2018-2023)
4.2.5 Europe Radiopharmaceuticals Market Size (2018-2023)
4.2.6 Asia-Pacific Radiopharmaceuticals Market Size (2018-2023)
4.2.7 Latin America Radiopharmaceuticals Market Size (2018-2023)
4.2.8 Middle East & Africa Radiopharmaceuticals Market Size (2018-2023)
5 North America
5.1 North America Radiopharmaceuticals Revenue by Countries
5.1.1 North America Radiopharmaceuticals Revenue by Countries (2018-2023)
5.1.2 North America Radiopharmaceuticals Sales by Countries (2018-2023)
5.2 North America Radiopharmaceuticals Sales by Types
5.3 North America Radiopharmaceuticals Sales by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Radiopharmaceuticals Revenue by Countries
6.1.1 Asia Pacific Radiopharmaceuticals Revenue by Countries (2018-2023)
6.1.2 Asia Pacific Radiopharmaceuticals Sales by Countries (2018-2023)
6.2 Asia Pacific Radiopharmaceuticals Sales by Types
6.3 Asia Pacific Radiopharmaceuticals Sales by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Radiopharmaceuticals Revenue by Countries
7.1.1 Europe Radiopharmaceuticals Revenue by Countries (2018-2023)
7.1.2 Europe Radiopharmaceuticals Sales by Countries (2018-2023)
7.2 Europe Radiopharmaceuticals Sales by Types
7.3 Europe Radiopharmaceuticals Sales by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Radiopharmaceuticals Revenue by Countries
8.1.1 Latin America Radiopharmaceuticals Revenue by Countries (2018-2023)
8.1.2 Latin America Radiopharmaceuticals Sales by Countries (2018-2023)
8.2 Latin America Radiopharmaceuticals Sales by Types
8.3 Latin America Radiopharmaceuticals Sales by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Radiopharmaceuticals Revenue by Countries
9.1.1 Middle East & Africa Radiopharmaceuticals Revenue by Countries (2018-2023)
9.1.2 Middle East & Africa Radiopharmaceuticals Sales by Countries (2018-2023)
9.2 Middle East & Africa Radiopharmaceuticals Sales by Types
9.3 Middle East & Africa Radiopharmaceuticals Sales by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Radiopharmaceuticals Market Competition, by Players
10.1 Global Radiopharmaceuticals Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Radiopharmaceuticals Players Market Share in 2022
10.2.2 Top 6 Radiopharmaceuticals Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Radiopharmaceuticals Players Head Office, Business Provided
10.4 Radiopharmaceuticals Mergers & Acquisitions
10.5 Radiopharmaceuticals New Entrants and Expansion Plans
11 Players Profiles
11.1 Cardinal Health (U.S.)
11.1.1 Cardinal Health (U.S.) Company Profile
11.1.2 Radiopharmaceuticals Product Overview
11.1.3 Cardinal Health (U.S.) Radiopharmaceuticals Market Performance (2018-2023)
11.1.4 Cardinal Health (U.S.) Business Overview
11.1.5 Recent Developments and Plans
11.2 GE Healthcare (U.S.)
11.2.1 GE Healthcare (U.S.) Company Profile
11.2.2 Radiopharmaceuticals Product Overview
11.2.3 GE Healthcare (U.S.) Radiopharmaceuticals Market Performance (2018-2023)
11.2.4 GE Healthcare (U.S.) Business Overview
11.2.5 Recent Developments and Plans
11.3 Lantheus Medical Imaging (U.S.)
11.3.1 Lantheus Medical Imaging (U.S.) Company Profile
11.3.2 Radiopharmaceuticals Product Overview
11.3.3 Lantheus Medical Imaging (U.S.) Radiopharmaceuticals Market Performance (2018-2023)
11.3.4 Lantheus Medical Imaging (U.S.) Business Overview
11.3.5 Recent Developments and Plans
11.4 Bayer AG (Germany)
11.4.1 Bayer AG (Germany) Company Profile
11.4.2 Radiopharmaceuticals Product Overview
11.4.3 Bayer AG (Germany) Radiopharmaceuticals Market Performance (2018-2023)
11.4.4 Bayer AG (Germany) Business Overview
11.4.5 Recent Developments and Plans
11.5 Bracco Imaging (Italy)
11.5.1 Bracco Imaging (Italy) Company Profile
11.5.2 Radiopharmaceuticals Product Overview
11.5.3 Bracco Imaging (Italy) Radiopharmaceuticals Market Performance (2018-2023)
11.5.4 Bracco Imaging (Italy) Business Overview
11.5.5 Recent Developments and Plans
11.6 Nordion (Canada)
11.6.1 Nordion (Canada) Company Profile
11.6.2 Radiopharmaceuticals Product Overview
11.6.3 Nordion (Canada) Radiopharmaceuticals Market Performance (2018-2023)
11.6.4 Nordion (Canada) Business Overview
11.6.5 Recent Developments and Plans
11.7 Advanced Accelerator Applications (France)
11.7.1 Advanced Accelerator Applications (France) Company Profile
11.7.2 Radiopharmaceuticals Product Overview
11.7.3 Advanced Accelerator Applications (France) Radiopharmaceuticals Market Performance (2018-2023)
11.7.4 Advanced Accelerator Applications (France) Business Overview
11.7.5 Recent Developments and Plans
11.8 NTP Radioisotopes (South Africa)
11.8.1 NTP Radioisotopes (South Africa) Company Profile
11.8.2 Radiopharmaceuticals Product Overview
11.8.3 NTP Radioisotopes (South Africa) Radiopharmaceuticals Market Performance (2018-2023)
11.8.4 NTP Radioisotopes (South Africa) Business Overview
11.8.5 Recent Developments and Plans
11.9 NorthStar Medical Radioisotopes (U.S.)
11.9.1 NorthStar Medical Radioisotopes (U.S.) Company Profile
11.9.2 Radiopharmaceuticals Product Overview
11.9.3 NorthStar Medical Radioisotopes (U.S.) Radiopharmaceuticals Market Performance (2018-2023)
11.9.4 NorthStar Medical Radioisotopes (U.S.) Business Overview
11.9.5 Recent Developments and Plans
11.10 Eckert & Ziegler (Germany)
11.10.1 Eckert & Ziegler (Germany) Company Profile
11.10.2 Radiopharmaceuticals Product Overview
11.10.3 Eckert & Ziegler (Germany) Radiopharmaceuticals Market Performance (2018-2023)
11.10.4 Eckert & Ziegler (Germany) Business Overview
11.10.5 Recent Developments and Plans
11.11 Braun Melsungen AG (Germany)
11.11.1 Braun Melsungen AG (Germany) Company Profile
11.11.2 Radiopharmaceuticals Product Overview
11.11.3 Braun Melsungen AG (Germany) Radiopharmaceuticals Market Performance (2018-2023)
11.11.4 Braun Melsungen AG (Germany) Business Overview
11.11.5 Recent Developments and Plans
11.12 Smith+Nephew (Germany)
11.12.1 Smith+Nephew (Germany) Company Profile
11.12.2 Radiopharmaceuticals Product Overview
11.12.3 Smith+Nephew (Germany) Radiopharmaceuticals Market Performance (2018-2023)
11.12.4 Smith+Nephew (Germany) Business Overview
11.12.5 Recent Developments and Plans
12 Global Radiopharmaceuticals Forecast Market Analysis by Type
12.1 Global Radiopharmaceuticals Revenue Market Forecast by Type (2023-2029)
12.2 Global Radiopharmaceuticals Sales Market Forecast by Type (2023-2029)
13 Global Radiopharmaceuticals Forecast Market Analysis by Application
13.1 Radiopharmaceuticals Revenue Market Forecast by Application (2023-2029)
13.2 Radiopharmaceuticals Sales Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Analysis
14.1 Global Radiopharmaceuticals Forecast Market Size (2023-2029)
14.2 Radiopharmaceuticals Growth Trends Forecast Analysis by Regions
14.2.1 Radiopharmaceuticals Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 Radiopharmaceuticals Sales Forecast Market Size by Regions (2023-2029)
14.2.3 North America Radiopharmaceuticals Forecast Market Size (2023-2029)
14.2.4 Europe Radiopharmaceuticals Forecast Market Size (2023-2029)
14.2.5 Asia-Pacific Radiopharmaceuticals Forecast Market Size (2023-2029)
14.2.6 Latin America Radiopharmaceuticals Forecast Market Size (2023-2029)
14.2.7 Middle East & Africa Radiopharmaceuticals Forecast Market Size (2023-2029)
15 Radiopharmaceuticals Manufacturing Cost Analysis
15.1 Radiopharmaceuticals Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Radiopharmaceuticals
15.4 Radiopharmaceuticals Industrial Chain Analysis
16 Market Channel, Distributors, Traders and Dealers
16.1 Market Channel Status
16.1.1 Direct Marketing
16.1.2 Indirect Marketing
16.2 Radiopharmaceuticals Typical Distributors
16.3 Radiopharmaceuticals Typical Customers
17 Radiopharmaceuticals Industry Dynamic Analysis
17.1 Radiopharmaceuticals Market Trends Analysis
17.2 Radiopharmaceuticals Market Drivers Analysis
17.3 Radiopharmaceuticals Market Challenges Analysis
17.4 Radiopharmaceuticals Market Restraints Analysis
18 Research Findings and Conclusion
Tables & Figures:
List of Tables and Figures
Figure Radiopharmaceuticals Picture
Table Product Definition of Radiopharmaceuticals
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Radiopharmaceuticals Market Size by Type (2018 VS 2023 VS 2029)
Table Global Radiopharmaceuticals Revenue and Market Size by Type (2018-2023)
Table Global Radiopharmaceuticals Revenue and Market Share by Type (2018-2023)
Table Global Radiopharmaceuticals Sales and Market Size by Type (2018-2023)
Table Global Radiopharmaceuticals Sales and Market Share by Type (2018-2023)
Table Global Radiopharmaceuticals Market Size by Application (2018 VS 2023 VS 2029)
Table Global Radiopharmaceuticals Revenue Market Size by Application (2018-2023)
Table Global Radiopharmaceuticals Revenue Market Share by Application (2018-2023)
Table Global Radiopharmaceuticals Sales Market Size by Application (2018-2023)
Table Global Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Figure Global Radiopharmaceuticals Revenue Market Size (2018-2023)
Figure Global Radiopharmaceuticals Sales Market Size (2018-2023)
Table Radiopharmaceuticals Market Size by Regions: 2018 VS 2023 VS 2029
Table Radiopharmaceuticals Historic Revenue Market Size by Regions (2018-2023)
Table Radiopharmaceuticals Historic Revenue Market Share by Regions (2018-2023)
Table Radiopharmaceuticals Historic Sales Market Size by Regions (2018-2023)
Table Radiopharmaceuticals Historic Sales Market Share by Regions (2018-2023)
Figure North America Radiopharmaceuticals Market Size (2018-2023)
Figure Europe Radiopharmaceuticals Market Size (2018-2023)
Figure Asia-Pacific Radiopharmaceuticals Market Size (2018-2023)
Figure Latin America Radiopharmaceuticals Market Size (2018-2023)
Figure Middle East & Africa Radiopharmaceuticals Market Size (2018-2023)
Table North America Radiopharmaceuticals Revenue by Countries (2018-2023)
Table North America Radiopharmaceuticals Revenue Market Share by Countries (2018-2023)
Table North America Radiopharmaceuticals Sales by Countries (2018-2023)
Table North America Radiopharmaceuticals Sales Market Share by Countries (2018-2023)
Table North America Radiopharmaceuticals Sales by Types (2018-2023)
Table North America Radiopharmaceuticals Sales Market Share by Types (2018-2023)
Table North America Radiopharmaceuticals Sales by Applications (2018-2023)
Table North America Radiopharmaceuticals Sales Market Share by Applications (2018-2023)
Figure United States Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure United States Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Canada Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Canada Radiopharmaceuticals Sales and Growth (2018-2023)
Table Asia-Pacific Radiopharmaceuticals Revenue by Countries (2018-2023)
Table Asia-Pacific Radiopharmaceuticals Revenue Market Share by Countries (2018-2023)
Table Asia-Pacific Radiopharmaceuticals Sales by Countries (2018-2023)
Table Asia-Pacific Radiopharmaceuticals Revenue Market Share by Countries (2018-2023)
Table Asia Pacific Radiopharmaceuticals Sales by Types (2018-2023)
Table Asia Pacific Radiopharmaceuticals Sales Market Share by Types (2018-2023)
Table Asia Pacific Radiopharmaceuticals Sales by Applications (2018-2023)
Table Asia Pacific Radiopharmaceuticals Sales Market Share by Applications (2018-2023)
Figure China Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure China Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Japan Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Japan Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Korea Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Korea Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Southeast Asia Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Southeast Asia Radiopharmaceuticals Sales and Growth (2018-2023)
Figure India Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure India Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Australia Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Australia Radiopharmaceuticals Sales and Growth (2018-2023)
Table Europe Radiopharmaceuticals Revenue by Countries (2018-2023)
Table Europe Radiopharmaceuticals Revenue Market Share by Countries (2018-2023)
Table Europe Radiopharmaceuticals Sales by Countries (2018-2023)
Table Europe Radiopharmaceuticals Sales Market Share by Countries (2018-2023)
Table Europe Radiopharmaceuticals Sales by Types (2018-2023)
Table Europe Radiopharmaceuticals Sales Market Share by Types (2018-2023)
Table Europe Radiopharmaceuticals Sales by Applications (2018-2023)
Table Europe Radiopharmaceuticals Sales Market Share by Applications (2018-2023)
Figure Germany Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Germany Radiopharmaceuticals Sales and Growth (2018-2023)
Figure France Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure France Radiopharmaceuticals Sales and Growth (2018-2023)
Figure UK Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure UK Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Italy Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Italy Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Russia Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Russia Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Spain Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Spain Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Nordic Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Nordic Radiopharmaceuticals Sales and Growth (2018-2023)
Table Latin America Radiopharmaceuticals Revenue by Countries (2018-2023)
Table Latin America Radiopharmaceuticals Revenue Market Share by Countries (2018-2023)
Table Latin America Radiopharmaceuticals Sales by Countries (2018-2023)
Table Latin America Radiopharmaceuticals Sales Market Share by Countries (2018-2023)
Table Latin America Radiopharmaceuticals Sales by Types (2018-2023)
Table Latin America Radiopharmaceuticals Sales Market Share by Types (2018-2023)
Table Latin America Radiopharmaceuticals Sales by Applications (2018-2023)
Table Latin America Radiopharmaceuticals Sales Market Share by Applications (2018-2023)
Figure Brazil Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Brazil Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Argentina Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Argentina Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Mexico Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Mexico Radiopharmaceuticals Sales and Growth (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Revenue by Countries (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Revenue Market Share by Countries (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Sales by Countries (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Sales Market Share by Countries (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Sales by Types (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Sales Market Share by Types (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Sales by Applications (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Sales Market Share by Applications (2018-2023)
Figure Egypt Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Egypt Radiopharmaceuticals Sales and Growth (2018-2023)
Figure South Africa Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure South Africa Radiopharmaceuticals Sales and Growth (2018-2023)
Figure UAE Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure UAE Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Turkey Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Turkey Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Saudi Arabia Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Saudi Arabia Radiopharmaceuticals Sales and Growth (2018-2023)
Table Global Radiopharmaceuticals Revenue by Players (2018-2023)
Table Global Radiopharmaceuticals Revenue Market Share by Players (2018-2023)
Figure Global Top 3 Companies Revenue Share in 2022
Figure Global Top 6 Companies Revenue Share in 2022
Table Global Radiopharmaceuticals Players Market Concentration Ratio (CR5) (2018-2023)
Table Radiopharmaceuticals Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Cardinal Health (U.S.) Profile
Table Product Overview
Table Cardinal Health (U.S.) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Cardinal Health (U.S.) Sales and Growth Rate
Figure Cardinal Health (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table GE Healthcare (U.S.) Profile
Table Product Overview
Table GE Healthcare (U.S.) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure GE Healthcare (U.S.) Sales and Growth Rate
Figure GE Healthcare (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Lantheus Medical Imaging (U.S.) Profile
Table Product Overview
Table Lantheus Medical Imaging (U.S.) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Lantheus Medical Imaging (U.S.) Sales and Growth Rate
Figure Lantheus Medical Imaging (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bayer AG (Germany) Profile
Table Product Overview
Table Bayer AG (Germany) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Bayer AG (Germany) Sales and Growth Rate
Figure Bayer AG (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bracco Imaging (Italy) Profile
Table Product Overview
Table Bracco Imaging (Italy) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Bracco Imaging (Italy) Sales and Growth Rate
Figure Bracco Imaging (Italy) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Nordion (Canada) Profile
Table Product Overview
Table Nordion (Canada) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Nordion (Canada) Sales and Growth Rate
Figure Nordion (Canada) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Advanced Accelerator Applications (France) Profile
Table Product Overview
Table Advanced Accelerator Applications (France) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Advanced Accelerator Applications (France) Sales and Growth Rate
Figure Advanced Accelerator Applications (France) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table NTP Radioisotopes (South Africa) Profile
Table Product Overview
Table NTP Radioisotopes (South Africa) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure NTP Radioisotopes (South Africa) Sales and Growth Rate
Figure NTP Radioisotopes (South Africa) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table NorthStar Medical Radioisotopes (U.S.) Profile
Table Product Overview
Table NorthStar Medical Radioisotopes (U.S.) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure NorthStar Medical Radioisotopes (U.S.) Sales and Growth Rate
Figure NorthStar Medical Radioisotopes (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Eckert & Ziegler (Germany) Profile
Table Product Overview
Table Eckert & Ziegler (Germany) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Eckert & Ziegler (Germany) Sales and Growth Rate
Figure Eckert & Ziegler (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Braun Melsungen AG (Germany) Profile
Table Product Overview
Table Braun Melsungen AG (Germany) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Braun Melsungen AG (Germany) Sales and Growth Rate
Figure Braun Melsungen AG (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Smith+Nephew (Germany) Profile
Table Product Overview
Table Smith+Nephew (Germany) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Smith+Nephew (Germany) Sales and Growth Rate
Figure Smith+Nephew (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Global Radiopharmaceuticals Revenue Market Size Forecast by Type (2023-2029)
Table Global Radiopharmaceuticals Revenue Market Share Forecast by Type (2023-2029)
Table Global Radiopharmaceuticals Sales Market Size Forecast by Type (2023-2029)
Table Global Radiopharmaceuticals Sales Market Share Forecast by Type (2023-2029)
Table Global Radiopharmaceuticals Revenue Market Size by Application (2023-2029)
Table Global Radiopharmaceuticals Revenue Market Share by Application (2023-2029)
Table Global Radiopharmaceuticals Sales Market Size by Application (2023-2029)
Table Global Radiopharmaceuticals Sales Market Share by Application (2023-2029)
Figure Global Radiopharmaceuticals Revenue Forecast Market Size (2023-2029)
Figure Global Radiopharmaceuticals Sales Forecast Market Size (2023-2029)
Table Radiopharmaceuticals Revenue Forecast Market Size by Regions (2023-2029)
Table Radiopharmaceuticals Revenue Forecast Market Share by Regions (2023-2029)
Table Radiopharmaceuticals Sales Forecast Market Size by Regions (2023-2029)
Table Radiopharmaceuticals Sales Forecast Market Share by Regions (2023-2029)
Figure North America Radiopharmaceuticals Revenue Forecast Market Size (2023-2029)
Figure North America Radiopharmaceuticals Sales Forecast Market Size (2023-2029)
Figure Europe Radiopharmaceuticals Revenue Forecast Market Size (2023-2029)
Figure Europe Radiopharmaceuticals Sales Forecast Market Size (2023-2029)
Figure Asia-Pacific Radiopharmaceuticals Revenue Forecast Market Size (2023-2029)
Figure Asia-Pacific Radiopharmaceuticals Sales Forecast Market Size (2023-2029)
Figure Latin America Radiopharmaceuticals Revenue Forecast Market Size (2023-2029)
Figure Latin America Radiopharmaceuticals Sales Forecast Market Size (2023-2029)
Figure Middle East & Africa Radiopharmaceuticals Forecast Market Size (2023-2029)
Figure Middle East & Africa Radiopharmaceuticals Sales Forecast Market Size (2023-2029)
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Table Raw Materials Analysis
Table Labor Cost Analysis
Table Manufacturing Expenses Analysis
Figure Manufacturing Process Analysis of Radiopharmaceuticals
Figure Radiopharmaceuticals Industrial Chain Analysis
Table Distributors of Radiopharmaceuticals with Contact Information
Table Major Customers of Radiopharmaceuticals with Contact Information
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Research Methodology:
Global Radiopharmaceuticals Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|